Liquidia Corp (LQDA)
12.87
+0.01
(+0.08%)
USD |
NASDAQ |
May 31, 16:00
14.42
+1.55
(+12.04%)
After-Hours: 20:00
Liquidia Enterprise Value: 825.19M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 825.19M |
| May 30, 2024 | 824.42M |
| May 29, 2024 | 790.82M |
| May 28, 2024 | 780.89M |
| May 24, 2024 | 790.82M |
| May 23, 2024 | 822.90M |
| May 22, 2024 | 845.05M |
| May 21, 2024 | 854.21M |
| May 20, 2024 | 861.85M |
| May 17, 2024 | 812.97M |
| May 16, 2024 | 815.26M |
| May 15, 2024 | 780.89M |
| May 14, 2024 | 755.68M |
| May 13, 2024 | 769.43M |
| May 10, 2024 | 763.32M |
| May 09, 2024 | 795.40M |
| May 08, 2024 | 796.93M |
| May 07, 2024 | 822.90M |
| May 06, 2024 | 811.44M |
| May 03, 2024 | 819.08M |
| May 02, 2024 | 833.59M |
| May 01, 2024 | 848.10M |
| April 30, 2024 | 823.66M |
| April 29, 2024 | 794.25M |
| April 26, 2024 | 799.22M |
| Date | Value |
|---|---|
| April 25, 2024 | 785.82M |
| April 24, 2024 | 799.55M |
| April 23, 2024 | 830.06M |
| April 22, 2024 | 847.61M |
| April 19, 2024 | 856.00M |
| April 18, 2024 | 895.67M |
| April 17, 2024 | 899.49M |
| April 16, 2024 | 878.12M |
| April 15, 2024 | 885.75M |
| April 12, 2024 | 906.35M |
| April 11, 2024 | 1.012B |
| April 10, 2024 | 973.48M |
| April 09, 2024 | 983.40M |
| April 08, 2024 | 996.37M |
| April 05, 2024 | 1.041B |
| April 04, 2024 | 1.009B |
| April 03, 2024 | 1.013B |
| April 02, 2024 | 1.015B |
| April 01, 2024 | 980.35M |
| March 31, 2024 | 967.38M |
| March 28, 2024 | 1.038B |
| March 27, 2024 | 1.062B |
| March 26, 2024 | 1.127B |
| March 25, 2024 | 1.108B |
| March 22, 2024 | 1.188B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
25.06M
Minimum
Sep 03 2019
1.188B
Maximum
Mar 22 2024
267.38M
Average
217.06M
Median
Enterprise Value Benchmarks
| United Therapeutics Corp | 10.11B |
| AIM ImmunoTech Inc | 10.88M |
| Perspective Therapeutics Inc | 680.29M |
| Protalix BioTherapeutics Inc | 54.78M |
| Armata Pharmaceuticals Inc | 192.52M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -40.93M |
| Revenue (Quarterly) | 2.972M |
| Total Expenses (Quarterly) | 31.77M |
| EPS Diluted (Quarterly) | -0.54 |
| Gross Profit Margin (Quarterly) | 50.64% |
| Profit Margin (Quarterly) | -1.38K% |
| Earnings Yield | -12.12% |
| Normalized Earnings Yield | -10.94 |